Monarch Mental Health Group

Monarch Mental Health Group is a leading Australian healthcare provider specializing in interventional psychiatry and advanced mental health treatments. The organization operates a network of specialized clinics that provide evidence-based therapies for patients with treatment-resistant conditions, such as major depressive disorder and obsessive-compulsive disorder. Their core service offerings include Transcranial Magnetic Stimulation (TMS) and Spravato (esketamine) nasal spray, which serve as alternatives for individuals who have not responded to traditional antidepressants. Monarch employs a multidisciplinary team of psychiatrists, nurses, and psychologists to deliver integrated, patient-centered care. By focusing on innovative neuromodulation and pharmacological interventions, the group aims to improve clinical outcomes for complex psychiatric cases across Australia. They are recognized as one of the largest providers of TMS in the region, maintaining a strong focus on clinical excellence and patient safety.